A South Korean manufacturer which claims to develop the world's first AI-powered doll companion for seniors has recently registered its product in the United States.
Hyodol has recently announced that its AI companion doll of the same name has been registered as a medical device with the US Food and Drug Administration.
WHAT IT'S ABOUT
Hyodol describes its doll, first released in 2019, as a...
Researchers from Asan Medical Center, South Korea's largest hospital, have developed an AI-based system for analysing coronary artery images prior to coronary angioplasty.
Coronary angioplasty is a standard treatment to widen narrowed or blocked coronary arteries indicated in coronary artery diseases such as angina and heart attack.
FINDINGS
The Asan research team's AI system supports...
South Korean medical imaging AI company Neurophet has received second clearance for its brain image analysis software in the United States.
It obtained another 510(k) from the US Food and Drug Administration for the latest functionality on Neurophet Aqua that analyses multiple sclerosis and white matter hyperintensities using T2-FLAIR images.
The brain MRI scan-based analysis software, which...
Researchers from South Korea have built machine learning-based models that can predict mood episodes using only sleep and circadian rhythm data from wearable devices.
The team comprised researchers from the Institute for Basic Sciences (IBS), Korea Advanced Institute of Science and Technology (KAIST), and Korea University College of Medicine.
FINDINGS
In a study, which findings were published in...
Vuno receives second 510(k)
South Korean medical AI company Vuno has obtained a 510(k) clearance from the United States Food and Drug Administration for its chest X-ray analysis AI software.
The VunoMed Chest X-ray Triage quickly screens for pneumothorax and pleural effusion in chest X-ray images.
This FDA win is a second for Vuno, who first received a 510(k) for its brain image analysis AI in...
Lunit collabs with AstraZeneca, secures major deal in France
Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims to accelerate the time-consuming process of genomic testing as part of NSCLC identification and diagnosis by leveraging Lunit's AI. The latter's...
A consortium of research institutes in South Korea has been formed to promote the utilisation of AI and national supercomputers in discovering novel drugs for treating lung cancer.
According to a press statement, the following organisations will collaborate to develop and test AI for identifying novel drug candidates and predicting its efficacy:
DAAN Cancer Research Institute under Yonsei...
Neurophet sets up China JV
Medical imaging AI company Neurophet from South Korea has established a joint venture in China.
It recently signed an exclusive deal with LADO, one of the leading medical software providers in China, to market its AI-based software for quantifying levels of Alzheimer's disease biomarkers in PET images.
The deal, which also establishes a joint venture with LADO, aims...
South Korean medical AI company AITRICS has obtained clearance from the Ministry of Health, Vietnam for its AI software for predicting patient deterioration.
VitalCare utilises AI to analyse 19 types of EMR data of patients in general wards to predict possible death, ICU transfer, and cardiac arrest within six hours. It can also predict sepsis within four hours, cardiac arrest within 24 hours, as...
Biofourmis founder launches health LMM startup
Over a year after leaving biotechnology unicorn Biofourmis, ex-CEO and founder Kuldeep Singh Rajput recently announced that he set up a new health tech company focused on generative AI.
In a LinkedIn post, he shared that his newly founded startup, OutcomesAI, has partnered with SingHealth to deploy its large multi-modal model (LMM) called Glia,...
